Annual Shareholders Equity
$125.70 M
-$35.12 M-21.84%
December 31, 2023
Summary
- As of March 12, 2025, PYXS annual stockholders equity is $125.70 million, with the most recent change of -$35.12 million (-21.84%) on December 31, 2023.
- During the last 3 years, PYXS annual shareholders equity has risen by +$141.35 million (+903.48%).
- PYXS annual shareholders equity is now -51.90% below its all-time high of $261.31 million, reached on December 31, 2021.
Performance
PYXS Shareholders Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Shareholders Equity
$153.68 M
-$16.11 M-9.49%
September 30, 2024
Summary
- As of March 12, 2025, PYXS quarterly stockholders equity is $153.68 million, with the most recent change of -$16.11 million (-9.49%) on September 30, 2024.
- Over the past year, PYXS quarterly shareholders equity has increased by +$15.73 million (+11.41%).
- PYXS quarterly shareholders equity is now -41.19% below its all-time high of $261.31 million, reached on December 31, 2021.
Performance
PYXS Quarterly Shareholders Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Shareholders Equity Formula
Shareholders Equity = Total Assets − Total Liabilities
PYXS Shareholders Equity Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -21.8% | +11.4% |
| 3 y3 years | +903.5% | +5.8% |
| 5 y5 years | +4473.8% | +5.8% |
PYXS Shareholders Equity Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -51.9% | at low | -41.2% | +22.3% |
| 5 y | 5-year | -51.9% | +903.5% | -41.2% | +315.1% |
| alltime | all time | -51.9% | +903.5% | -41.2% | +315.1% |
Pyxis Oncology Shareholders Equity History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $153.68 M(-9.5%) |
| Jun 2024 | - | $169.79 M(-7.8%) |
| Mar 2024 | - | $184.16 M(+46.5%) |
| Dec 2023 | $125.70 M(-21.8%) | $125.70 M(-8.9%) |
| Sep 2023 | - | $137.95 M(-5.0%) |
| Jun 2023 | - | $145.28 M(-4.5%) |
| Mar 2023 | - | $152.16 M(-5.4%) |
| Dec 2022 | $160.82 M | $160.82 M(-14.8%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2022 | - | $188.75 M(-11.0%) |
| Jun 2022 | - | $211.97 M(-9.2%) |
| Mar 2022 | - | $233.51 M(-10.6%) |
| Dec 2021 | $261.31 M(-1770.3%) | $261.31 M(-465.8%) |
| Sep 2021 | - | -$71.44 M(+24.1%) |
| Jun 2021 | - | -$57.59 M(+268.1%) |
| Dec 2020 | -$15.64 M(+444.4%) | -$15.64 M |
| Dec 2019 | -$2.87 M | - |
FAQ
- What is Pyxis Oncology annual stockholders equity?
- What is the all time high annual shareholders equity for Pyxis Oncology?
- What is Pyxis Oncology annual shareholders equity year-on-year change?
- What is Pyxis Oncology quarterly stockholders equity?
- What is the all time high quarterly shareholders equity for Pyxis Oncology?
- What is Pyxis Oncology quarterly shareholders equity year-on-year change?
What is Pyxis Oncology annual stockholders equity?
The current annual shareholders equity of PYXS is $125.70 M
What is the all time high annual shareholders equity for Pyxis Oncology?
Pyxis Oncology all-time high annual stockholders equity is $261.31 M
What is Pyxis Oncology annual shareholders equity year-on-year change?
Over the past year, PYXS annual stockholders equity has changed by -$35.12 M (-21.84%)
What is Pyxis Oncology quarterly stockholders equity?
The current quarterly shareholders equity of PYXS is $153.68 M
What is the all time high quarterly shareholders equity for Pyxis Oncology?
Pyxis Oncology all-time high quarterly stockholders equity is $261.31 M
What is Pyxis Oncology quarterly shareholders equity year-on-year change?
Over the past year, PYXS quarterly stockholders equity has changed by +$15.73 M (+11.41%)